Integrative analysis of tp53 mutations in lung adenocarcinoma for immunotherapies and prognosis

HIGHLIGHTS

• who: He Li from the Department of Respiration, The University, Shijiazhuang, China have published the research work: Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis, in the Journal: (JOURNAL)
• what: The authors aimed to elucidate the association between TP53 mutations response to immunotherapies and the prognosis of LUAD. The authors aimed to use bioinformatics and statistical analyses of data collected from patients with LUAD from The study has not been confirmed in further experiment. The study provides valuable information and insights for future LUAD research.
• how: The workflow of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.